GDC-0152 Desiccators

GDC-0152 DesiccatorsGDC 0152 is a potent antagonist of XIAP BIR3, ML IAP BIR3, cIAP1 BIR3 and cIAP2 BIR3 with Ki of 28 nM, 14 nM, 17 nM and 43 nM in cell free assays, respectively; less affinity shown to cIAP1 BIR2 and cIAP2 BIR2. Phase 1.

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family

Standard PUE 7

NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM

differs from exendin-3 only in two positions close to the N-terminus

a new standard for  mass

Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits and inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins

Lomefloxacin HCl is a hydrochloride salt of lomefloxacin and is a fluoroquinolone antibiotic

Abl and p38

mainly oil of guaiac and chamomile oil

BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay

Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1

which is a direct-acting smooth muscle relaxant used to treat hypertension by acting as a vasodilator primarily in arteries and arterioles